Literature DB >> 393513

Methodological aspects of the evaluation of the binding of drugs to plasma and tissue proteins.

J P Tillement, E Albengres, S Urien.   

Abstract

This paper describes the methodological aspects of the evaluation of the binding of drugs to plasma and tissue proteins. The relevance of the procedures employed to certain problems in clinical-pharmacology as well as the role of plasma binding in drug distribution and pharmacokinetics are discussed. The possibly important role of plasma protein binding of some drugs is emphasized. The incidence of plasma binding on drug distribution and pharmacokinetics are developed and the possible incidence of pathological states on drug plasma binding are considered.

Mesh:

Substances:

Year:  1979        PMID: 393513     DOI: 10.1007/BF03189413

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  22 in total

1.  beta-Lipoproteins: possible plasma transport proteins for basic drugs.

Authors:  J J Vallner; L Chen
Journal:  J Pharm Sci       Date:  1977-03       Impact factor: 3.534

Review 2.  Diseases and drug protein binding.

Authors:  J P Tillement; F Lhoste; J F Giudicelli
Journal:  Clin Pharmacokinet       Date:  1978 Mar-Apr       Impact factor: 6.447

3.  Plasma protein binding of basic drugs. II. Importance of alpha 1-acid glycoprotein for interindividual variation.

Authors:  K M Piafsky; O Borgå
Journal:  Clin Pharmacol Ther       Date:  1977-11       Impact factor: 6.875

Review 4.  Binding of drugs by albumin and plasma protein.

Authors:  J J Vallner
Journal:  J Pharm Sci       Date:  1977-04       Impact factor: 3.534

5.  Metabolism of valproate sodium in rabbit, rat, dog, and man.

Authors:  B Ferrandes; P Eymard
Journal:  Epilepsia       Date:  1977-06       Impact factor: 5.864

6.  Binding of adrenergic beta-receptor antagonists to human serum albumin.

Authors:  C Appelgren; K O Borg; R Elofsson; K A Johansson
Journal:  Acta Pharm Suec       Date:  1974-09

7.  Plasma protein binding of basic drugs. I. Selective displacement from alpha 1-acid glycoprotein by tris(2-butoxyethyl) phosphate.

Authors:  O Borgå; K M Piafsky; O G Nilsen
Journal:  Clin Pharmacol Ther       Date:  1977-11       Impact factor: 6.875

8.  Pharmacokinetics of di-n-propylacetate in epileptic patients.

Authors:  F Schobben; E van der Kleijn; F J Gabreëls
Journal:  Eur J Clin Pharmacol       Date:  1975-02-28       Impact factor: 2.953

Review 9.  Sodium valproate: a review of its pharmacological properties and therapeutic efficacy in epilepsy.

Authors:  R M Pinder; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-02       Impact factor: 9.546

10.  Binding of quinidine to plasma proteins in normal subjects and in patients with hyperlipoproteinemias.

Authors:  R E Kates; T D Sokoloski; T J Comstock
Journal:  Clin Pharmacol Ther       Date:  1978-01       Impact factor: 6.875

View more
  2 in total

1.  Reduction in biliary excretion of ceftriaxone by diclofenac in rabbits.

Authors:  M Merle-Melet; N Seta; R Farinotti; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

2.  Binding of Tienilic acid (Diflurex) to human plasma proteins and erythrocytes.

Authors:  C Plessas; A Benakis
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1980       Impact factor: 2.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.